Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The introduction of immunotherapy and its ultimate success will require re-evaluation of the pathogenesis of Alzheimer's disease particularly with regard to the role of the ageing microvasculature and the effects of APOE genotype. Arteries in the brain have two major functions (a) delivery of blood and (b) elimination of interstitial fluid and solutes, including amyloid-beta (Abeta), along perivascular pathways (lymphatic drainage). Both these functions fail with age and particularly severely in Alzheimer's disease and vascular dementia. Accumulation of Abeta as plaques in brain parenchyma and artery walls as cerebral amyloid angiopathy (CAA) is associated with failure of perivascular elimination of Abeta from the brain in the elderly and in Alzheimer's disease. High levels of soluble Abeta in the brain correlate with cognitive decline in Alzheimer's disease and reflect the failure of perivascular drainage of solutes from the brain and loss of homeostasis of the neuronal environment. Clinically and pathologically, there is a spectrum of disease related to functional failure of the ageing microvasculature with "pure" Alzheimer's disease at one end of the spectrum and vascular dementia at the other end. Changes in the cerebral microvasculature with age have a potential impact on therapy with cholinesterase inhibitors and especially on immunotherapy that removes Abeta from plaques in the brain, but results in an increase in severity of CAA and no clear improvement in cognition. Drainage of Abeta along perivascular pathways in ageing artery walls may need to be improved to maximise the potential for improvement of cognitive function with immunotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in Alzheimer disease and CAA, accumulation of Aβ in the media of cortical arterioles weakens the vessel wall and increases the chance of lobar hemorrhages.109”
In the citing paper
“CAA is a major cause of SMC vascular degeneration that is associated with BBB breakdown at the arterial and/or arteriolar level, lobar microbleeds, infarcts, white matter changes, and cognitive impairment worsening AD pathology (514, 640).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [640]
In the citing paper
“Such white matter alterations cannot be fully accounted for as degenerative processes secondary to grey matter damage (Brun and Englund, 1986; Englund, 1998; Agosta et al., 2011), but may stem from vascular amyloid deposition and microvascular damage (Weller et al., 2009).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Weller et al., 2009
In the citing paper
“CAA is caused by A 𝛃 deposition in the vascular wall of small brain arteries and capillaries and develops as a result of an imbalance between A 𝛃 production and clearance, particularly faulty transvascular and perivascular clearance of A 𝛃 from the brain (318, 420, 581, 640).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [640]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · cited 1×
“A is derived from the enzymic cleavage of the transmembrane amyloid precursor protein (APP) [76, 77] resulting in a small pool of soluble A in normal brain [43].”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 2×
“brain and eventually the rise in levels of soluble A in Alzheimer’s disease [49, 51] reXect the failure of mechanisms by which A is normally eliminated from the brain [92].”
BackgroundHolmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416
Self-citationShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
(1964) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,409
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 1×
“Subsequent studies have conWrmed that clearance of A plaques can occur as a result of immunotherapy in humans with Alzheimer’s disease (Elan Pharmaceuticals AN1792) [16, 30, 37, 50, 56, 57], although there is little evidence yet that this beneWts cognitive function [37].”
BackgroundSelf-citationSubacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Orgogozo, J.-M., Gilman, S., Dartigues, J.-F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000073623.84147.a8 · Cited by 1,356 · cited 1×
“cern in the human clinical trials [59].”
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · cited 1×
“The hypothesis is now testable because of the recent ability to image amyloid plaques in vivo using PIB PET imaging [ 39 ] and it is likely that the relevant data with which to test the hypothesis will be available soon.”
BackgroundCortical blood vessels of the human brain
Duvernoy, H. M., Delon, S., & Vannson, J. L. (1981) · Brain Research Bulletin · doi:10.1016/0361-9230(81)90007-1 · Cited by 839 · cited 3×
“through the cortical layers without branching [24].”
BackgroundInfluentialRoher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799 · cited 1×
“A 42 in Alzheimer’s disease is predominantly in the plaques [69] and the more soluble”
BackgroundEvidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
Abbott, N. J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.006 · Cited by 786 · cited 5×
“Pericapillary basement membranes are in direct contact with the narrow and restricted extracellular (interstitial) spaces between the neuronal and glial processes of the grey matter (Fig. 6). Interstitial Xuid and solutes secreted by the capillary endothelium are distributed by bulk Xow along pericapillary basement me…”
BackgroundInfluentialWeller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00133.x · Cited by 681 · cited 10×
“The distribution of A in the basement membranes of capillary and artery walls and in the adventitia of leptomeningeal arteries in CAA [86, 92] corresponds exactly with the pathways outlined by tracers in the experimental studies [17, 80].”
BackgroundMethodInfluentialSelf-citationWeller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
Self-citationBell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Carare, R. O., Bernardes‐Silva, M., Newman, T. A., Page, A. M., Nicoll, J. A. R., Perry, V. H., & Weller, R. O. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00926.x · Cited by 665
Self-citationCirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view
Cserr, H. F., & Knopf, P. M. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90027-5 · Cited by 653 · cited 1×
“1. The distribution of A in the basement membranes of capillaries and arteries and its presence in the adventitia of leptomeningeal arteries corresponds exactly to the distribution of tracers injected into the brain to outline perivascular lymphatic drainage pathways for the elimination of Xuid and solutes from the br…”
BackgroundWater-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587 · cited 4×
“Leukoaraiosis in the subcortical white matter, however, has been correlated with arteriolosclerosis in arteries in the white matter and with markers of tissue hypoxia [ 29 ].”
BackgroundInfluentialWhat is the blood–brain barrier (not)?
Bechmann, I., Galea, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.007 · Cited by 520
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., & Smith, A. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02355-7 · Cited by 493 · cited 3×
“The main pathological consequences of hypoperfusion are lacunar infarcts in the basal ganglia, microinfarcts in the cerebral cortex, especially in the water-shed zones, and leukoaraiosis of the cerebral white matter [26, 48].”
BackgroundLymphatic drainage of the brain and the pathophysiology of neurological disease
Weller, R. O., Djuanda, E., Yow, H.-Y., & Carare, R. O. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0457-0 · Cited by 488 · cited 10×
“The drainage pathway for interstitial Xuid is largely separate from the CSF in the normal CNS [80, 90].”
BackgroundInfluentialSelf-citationFerrer, I., Rovira, M. B., Guerra, M. L. S., Rey, M. J., & Costa‐Jussá, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00493.x · Cited by 479
(1990) · Europe PMC (PubMed Central) · Cited by 463
Self-citationTwo Types of Sporadic Cerebral Amyloid Angiopathy
Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446 · cited 1×
“Capillary CAA has been associated with a high frequency apolipoprotein E 4 genotype [82] and with Alzheimer’s disease pathology [4], but does not correlate with CAA of leptomeningeal and cortical arteries [3, 5, 82].”
BackgroundWilcock, D. M., Rojiani, A. M., Rosenthal, A., Subbarao, S., Freeman, M. J., Gordon, M. N., & Morgan, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-24 · Cited by 420
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384 · cited 8×
“ease [81] may be related to the structure of the artery walls.”
BackgroundInfluentialMiners, J. S., Baig, S., Palmer, J., Palmer, L. E., Kehoe, P. G., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00132.x · Cited by 381 · cited 1×
“walls [ 52 ]. A is also absorbed into the blood by mechanisms involving LRP-1 [12, 78], and p-glycoprotein [20].”
BackgroundBlack, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379
Scolding, N. J. (2005) · Brain · doi:10.1093/brain/awh379 · Cited by 372 · cited 1×
“Granulomatous inXammation may also occur in relation to amyloid laden vessels in CAA [ 75 ].”
BackgroundRole of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease
Deane, R., & Zlokovic, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362245 · Cited by 365 · cited 1×
“Particularly relevant to Alzheimer’s disease is the absorption of A by receptormediated pathways involving lipoprotein receptor-related protein-1 (LRP-1) [12, 78], p-glycoprotein [20] and receptor for advanced glycation end products (RAGE) [22].”
BackgroundDrainage of interstitial fluid from different regions of rat brain
Szentistvanyi, I., Patlak, C. S., Ellis, R. A., & Cserr, H. F. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.246.6.f835 · Cited by 355
Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
Masliah, E., Hansen, L., Adame, A., Crews, L., Bard, F., Lee, C., Seubert, P., Games, D., Kirby, L., & Schenk, D. (2005) · Neurology · doi:10.1212/01.wnl.0000148590.39911.df · Cited by 353
Perivascular Spaces and the Two Steps to Neuroinflammation
Owens, T., Bechmann, I., & Engelhardt, B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818f9ca8 · Cited by 353
Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain
Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., Wilkinson, D., Holmes, C., & Nicoll, J. A. R. (2008) · Brain · doi:10.1093/brain/awn261 · Cited by 316
Self-citationMechanisms to explain the reverse perivascular transport of solutes out of the brain
Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., & Weller, R. O. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.07.005 · Cited by 293 · cited 4×
“This mechanism would require a valve-like action to prevent back Xow of Xuid during passage of the pulse wave [72].”
BackgroundInfluentialSelf-citationCerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View
Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 288 · cited 2×
“A number of amyloidogenic proteins are involved in diVerent types of CAA [67].”
BackgroundRoher, A. E., Kuo, Y.-M., Esh, C., Knebel, C., Weiss, N., Kalback, W., Luehrs, D. C., Childress, J. L., Beach, T. G., Weller, R. O., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402043 · Cited by 276 · cited 4×
“123 white matter in leukoaraiosis [68].”
BackgroundInfluentialSelf-citationNeuropathological evaluation of mixed dementia
Jellinger, K. A., & Attems, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.045 · Cited by 272 · cited 3×
“dementia but they also occur in cases of mixed dementia in which the features of Alzheimer’s disease and vascular dementia are present in the same brain [41].”
BackgroundLossinsky, A. S., & Shivers, R. R. (2004) · PubMed · doi:10.14670/hh-19.535 · Cited by 272
Aβ Species Removal After Aβ 42 Immunization
Nicoll, J. A. R., Barton, E., Boche, D., Neal, J. W., Ferrer, I., Thompson, P., Vlachouli, C., Wilkinson, D., Bayer, A., Games, D., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240466.10758.ce · Cited by 265 · cited 2×
“However, the observation that APOE colocalises with the marked vascular accumulation of A following immunotherapy [56], is consistent with the mobilised A being transported or chaperoned by apoE, as it is in Alzheimer’s disease.”
BackgroundSelf-citationThe Cranial Arachnoid and Pia Mater in Man: Anatomical and Ultrastructural Observations
ALCOLADO, R., WELLER, R. O., PARRISH, E. P., & GARROD, D. (1988) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1988.tb00862.x · Cited by 252 · cited 1×
“blood supply to the cerebral cortex and identiWes the tissue components of the artery and capillary walls that appear to form the lymphatic drainage pathways of the human brain [2, 38, 89, 98].”
BackgroundSelf-citationThe amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
Glenner, G. G., Wong, C. W., Quaranta, V., & Eanes, E. D. (1984) · PubMed · Cited by 244
Preston, S. D., Steart, P. V., Wilkinson, A., Nicoll, J. A. R., & Weller, R. O. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00424.x · Cited by 239
Self-citationAnatomical relationships of the pia mater to cerebral blood vessels in man
Hutchings, M., & Weller, R. O. (1986) · Journal of Neurosurgery · doi:10.3171/jns.1986.65.3.0316 · Cited by 233 · cited 1×
“blood supply to the cerebral cortex and identiWes the tissue components of the artery and capillary walls that appear to form the lymphatic drainage pathways of the human brain [2, 38, 89, 98].”
BackgroundSelf-citationIncreased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs
Perry, E. K., Kilford, L., Lees, A. J., Burn, D. J., & Perry, R. H. (2003) · Annals of Neurology · doi:10.1002/ana.10639 · Cited by 231 · cited 1×
“Patients with dementia with Lewy bodies who were treated with cholinesterase inhibitors were found to have signiWcantly reduced levels of parenchymal A deposition [6], whereas blockade of muscarinic receptors in patients with Parkinson’s disease resulted in a 2.5-fold increase in the density of A plaques [ 63 ].”
BackgroundInfluentialWeller, R. O. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199810000-00001 · Cited by 224 · cited 1×
“The periventricular white matter lesions may indicate a disturbance of CSF drainage and the infusion of CSF into periventricular white matter [ 88 , 90].”
BackgroundSelf-citationPerivascular spaces in the basal ganglia of the human brain: their relationship to lacunes
POLLOCK, H., HUTCHINGS, M., WELLER, R. O., & ZHANG, E. (1997) · Journal of Anatomy · doi:10.1046/j.1469-7580.1997.19130337.x · Cited by 220 · cited 2×
“4, 5) [ 65 ] that may facilitate the drainage of interstitial Xuid and A from the basal ganglia.”
BackgroundSelf-citationFarkas, E., De Jong, G. I., de Vos, R. A. I., Jansen Steur, E. N. H., & Luiten, P. G. M. (2000) · Acta Neuropathologica · doi:10.1007/s004010000195 · Cited by 217 · cited 2×
“These changes in capillary basement membranes may aVect blood Xow, transfer of nutrients from blood to brain [27, 28] and the perivascular drainage of Xuid and solutes from the brain [90, 92].”
BackgroundGiant tumefactive perivascular spaces.
Salzman, K. L., Osborn, A. G., House, P. A., Jinkins, J. R., Ditchfield, A., Cooper, J. A., & Weller, R. O. (2005) · PubMed Central · Cited by 195
Self-citationThe Cerebral β-Amyloid Angiopathies: Hereditary and Sporadic
Zhang-Nunes, S. X., Maat-Schieman, M. L. C., Duinen, S. G., Roos, R. A. C., Frosch, M. P., & Greenberg, S. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00559.x · Cited by 193 · cited 1×
“The most devastating is acute intracerebral haemorrhage associated with sporadic or familial CAA [97].”
BackgroundAmyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients
Patton, R. L., Kalback, W. M., Esh, C. L., Kokjohn, T. A., Van Vickle, G. D., Luehrs, D. C., Kuo, Y.-M., Lopez, J., Brune, D., Ferrer, I., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060269 · Cited by 192
T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa
Goldmann, J., Kwidzinski, E., Brandt, C., Mahlo, J., Richter, D., & Bechmann, I. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306176 · Cited by 188
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology?a pilot study
Attems, J., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0796-9 · Cited by 181 · cited 1×
“Capillary CAA has been associated with a high frequency apolipoprotein E 4 genotype [82] and with Alzheimer’s disease pathology [4], but does not correlate with CAA of leptomeningeal and cortical arteries [3, 5, 82].”
BackgroundImmune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
Engelhardt, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.019 · Cited by 180 · cited 1×
“Postcapillary venules are the site for the receptor-mediated entry of inXammatory cells into the brain [10, 25].”
BackgroundScholz, W. (1938) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890989 · Cited by 180
Fisher, A. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.002 · Cited by 175 · cited 3×
“Treatment of Alzheimer’s disease with cholinesterase inhibitors is well established [32] and immunotherapy for the clearance of A plaques from the brain is under development [37].”
BackgroundMicroscopic morphology and histology of the human meninges
Weller, R. O. (2005) · Morphologie · doi:10.1016/s1286-0115(05)83235-7 · Cited by 175 · cited 2×
“A perivascular space separates the two layers of leptomeninges (reproduced with permission from reference [ 89 ]) 90 Acta Neuropathol (2009) 118:87–102”
BackgroundSelf-citationBrain Parenchymal and Microvascular Amyloid in Alzheimer's Disease
Vinters, H. V., Wang, Z. Z., & Secor, D. L. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00799.x · Cited by 171 · cited 2×
“The distribution of A in the basement membranes of capillary and artery walls and in the adventitia of leptomeningeal arteries in CAA [86, 92] corresponds exactly with the pathways outlined by tracers in the experimental studies [17, 80].”
BackgroundMethodMechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
Herzig, M. C., Nostrand, W. E., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 169 · cited 7×
“Transgenic mice that produce excessive amounts of A only in neurons develop CAA [36].”
BackgroundInfluentialHatterer, E., Davoust, N., Didier-Bazes, M., Vuaillat, C., Malcus, C., Belin, M.-F., & Nataf, S. (2006) · Blood · doi:10.1182/blood-2005-01-0154 · Cited by 166
Attems, J., Lintner, F., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0822-6 · Cited by 163
?-Amyloid formation by myocytes of leptomeningeal vessels
Wisniewski, H. M., & Wegiel, J. (1994) · Acta Neuropathologica · doi:10.1007/bf00296738 · Cited by 162
Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease
Nicoll, J. A. R., Yamada, M., Frackowiak, J., Mazur-Kolecka, B., & Weller, R. O. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.003 · Cited by 160 · cited 3×
“Most cells in the body produce A [77] including smooth muscle cells in the walls of cerebral arteries [58, 95].”
BackgroundSelf-citationTsubuki, S., Takai, Y., & Saido, T. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13555-6 · Cited by 158
Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Diseasea
MOODY, D. M., BROWN, W. R., CHALLA, V. R., GHAZI‐BIRRY, H. S., & REBOUSSIN, D. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48464.x · Cited by 157 · cited 1×
“Arterioles also show an increase in tortuosity with age, particularly in the white matter [54].”
BackgroundThe Pathology of “Vascular Dementia”: A Critical Update
Jellinger, K. A. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14110 · Cited by 155 · cited 2×
“dementia the features of Alzheimer pathology and ischaemic lesions appear to act synergistically [40, 41].”
BackgroundMiners, J. S., Van Helmond, Z., Chalmers, K., Wilcock, G., Love, S., & Kehoe, P. G. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000240463.87886.9a · Cited by 154 · cited 2×
“in CAA [53].”
BackgroundBeach, T. G., Kuo, Y.-M., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., & Roher, A. E. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.308 · Cited by 154
Hart, M. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181839bfd · Cited by 145
Attems, J., Quass, M., Jellinger, K. A., & Lintner, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.013 · Cited by 141
Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seubert, P., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2377-07.2008 · Cited by 133 · cited 1×
“reduction in CAA severity [74].”
Shinkai, Y., Yoshimura, M., Ito, Y., Odaka, A., Suzuki, N., Yanagisawa, K., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410380312 · Cited by 127 · cited 4×
“A has been detected biochemically in the walls of cerebral arteries in individuals at the age of 20 years and not just in the elderly [79].”
BackgroundInfluentialAge-related microvascular degeneration in the human cerebral periventricular white matter
Farkas, E., de Vos, R. A. I., Donka, G., Steur, E. N. H. J., Mihály, A., & Luiten, P. G. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0007-y · Cited by 118 · cited 2×
“These changes in capillary basement membranes may aVect blood Xow, transfer of nutrients from blood to brain [27, 28] and the perivascular drainage of Xuid and solutes from the brain [90, 92].”
BackgroundBoche, D., & Nicoll, J. A. R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00134.x · Cited by 104
Self-citationMechanical properties of human cerebral arteries.
Hayashi, K., Nagasawa, S., Naruo, Y., Okumura, A., Moritake, K., & Handa, H. (1980) · PubMed · Cited by 91
Tian, J., Shi, J., Bailey, K., & Mann, D. M. A. (2004) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00510.x · Cited by 89 · cited 1×
“Arteriolosclerosis (lipohyalinosis, hyalinosis [31]) aVects the arterioles in the grey and white matter of the cerebral hemispheres [81, 84].”
BackgroundWELLER, R. O., YOW, H., PRESTON, S. D., MAZANTI, I., & NICOLL, J. A. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04812.x · Cited by 82
Self-citationThe ubiquitin–proteasome system and neurodegenerative disorders
Layfield, R., Lowe, J. S., & Bedford, L. (2005) · Essays in Biochemistry · doi:10.1042/eb0410157 · Cited by 78 · cited 1×
“ciated with the failure of the ubiquitin–proteasome system to dispose of hyperphosphorylated tau from ageing neurons [11, 46].”
BackgroundRationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Lahiri, D., Rogers, J., Greig, N., & Sambamurti, K. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383331 · Cited by 76 · cited 1×
“by a reduction in the cholinergic system in the brain [7, 44].”
BackgroundLowe, J. S., Mirra, S. S., Hyman, B. T., & Dickson, D. W. (2008) · CRC Press eBooks · doi:10.1201/b13319-15 · Cited by 72 · cited 4×
“NeuroWbrillary tangles (NFT) within neurons in the brain are composed largely of ubiquitin and the microtubule-associated protein tau [48].”
BackgroundInfluentialCholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition
Beach, T. G., Potter, P. E., Kuo, Y.-M., Emmerling, M. R., Durham, R. A., Webster, S. D., Walker, D. G., Sue, L. I., Scott, S., Layne, K. J., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00916-2 · Cited by 71 · cited 2×
“Biochemical measurements revealed a 2.5- and 8fold elevations of cortical A40 and A42, respectively [ 9 ].”
BackgroundInfluentialKuo, Y.-M., Crawford, F., Mullan, M., Kokjohn, T. A., Emmerling, M. R., Weller, R. O., & Roher, A. E. (2000) · Molecular Medicine · doi:10.1007/bf03401785 · Cited by 69
Self-citationCholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies
Ballard, C. G., Chalmers, K. A., Todd, C., McKeith, I. G., O’Brien, J. T., Wilcock, G., Love, S., & Perry, E. K. (2007) · Neurology · doi:10.1212/01.wnl.0000261920.03297.64 · Cited by 67
Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease
Domnitz, S. B., Robbins, E. M., Hoang, A. W., Garcia-Alloza, M., Hyman, B. T., Rebeck, G. W., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171644.00180.fc · Cited by 67
Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease
Tian, J., Shi, J., Bailey, K. L., & Mann, D. M. A. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.048 · Cited by 61 · cited 1×
“In community studies there is an association between severe CAA and dementia [18] but both positive [81] and negative [83] correlations between CAA and A plaques in Alzheimer’s disease have been made.”
BackgroundNagasawa, S., Handa, H., Okumura, A., Naruo, Y., Moritake, K., & Hayashi, K. (1979) · PubMed · Cited by 61
Contributors to white matter damage in the frontal lobe in Alzheimer's disease
Chalmers, K., Wilcock, G., & Love, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00678.x · Cited by 57 · cited 1×
“Leukoaraiosis has also been correlated with amyloid load in the brain parenchyma [19] and with severe CAA in the leptomeningeal arteries from which the arterial supply of the white matter arises [68].”
BackgroundEvolving Concepts of Cerebrospinal Fluid Physiology
Bergsneider, M. (2001) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30021-4 · Cited by 55
[The concept of cerebral lacunae from 1838 to the present].
Poirier, J. C., & Derouesné, C. (1985) · PubMed · Cited by 40
Amyloid β-peptide is produced by cultured cells during normal metabolism: A reprise
Selkoe, D. J. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s319 · Cited by 39
Physiologic Origins of Age-Related β-Amyloid Deposition
Beach, T. G. (2008) · Neurodegenerative Diseases · doi:10.1159/000113685 · Cited by 37
Bedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 36
Ferrer, I., Kaste, M., & Kalimo, H. (2008) · CRC Press eBooks · doi:10.1201/b13319-4 · Cited by 33
Lashley, T., Revesz, T., Plant, G., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., De Silva, R., Ghiso, J., Rostagno, A., et al. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00935.x · Cited by 31 · cited 2×
“They include cystatin, transthyretin, gesolin, prion protein [67] and the amyloid deposited in the vessel walls in the British and Danish types of dementia [45].”
BackgroundOshima, K., Akiyama, H., Tsuchiya, K., Kondo, H., Haga, C., Shimomura, Y., Iseki, E., Uchikado, H., Kato, M., Niizato, K., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0070-z · Cited by 25
Yow, H. Y., & Weller, R. O. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.39286_4.x · Cited by 17
Self-citation(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m · cited 2×
“disease [49, 51] and (3) the accumulation of Xuid in the”
Background
Research works printed but not linked: 1
- Poirier J, Derouesne C (1985) Le concept de lacune cerebrale de 1838 a nos jours. Rev Neurol 141:3–17
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Sperling, R. A., Jack, C. R., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., Scheltens, P., Carrillo, M. C., Thies, W., Bednar, M. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2351 · Cited by 857
Glymphatic MRI in idiopathic normal pressure hydrocephalus
Ringstad, G., Vatnehol, S. A. S., & Eide, P. K. (2017) · Brain · doi:10.1093/brain/awx191 · Cited by 722
“Presence of soluble amyloid-b deposits in the walls of leptomeningeal arteries has previously led to the conclusion that CSF and solutes exit the brain along arteries (Weller et al., 2009).”
Background
Metadata
- Authors
- Weller, R. O., Boche, D., & Nicoll, J. A. R.
- Affiliations
- Southampton General Hospital (GB)
- Corresponding author
- Weller, Roy O.
- Venue
- Acta Neuropathologica
- Published
- 2009-02-22
- Volume
- 118
- Issue
- 1
- Pages
- 87-102
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2128307173
- Cited by
- 297
- References
- 101
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 11 · 2020: 20 · 2019: 13 · 2018: 23 · 2017: 15 · 2016: 16 · 2015: 23 · 2014: 27 · 2013: 24 · 2012: 17
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Funders
- University of Southampton
- Chinese Academy of Agricultural Sciences
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Alzheimer's disease, cerebral amyloid angiopathy, cerebral microvasculature, aging, amyloid-beta, APOE genotype, immunotherapy, cholinesterase inhibitors, vascular dementia, cognitive decline, amyloid plaques
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Cholinesterase Inhibitors, Humans, Dementia, Vascular, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.